SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001144204-13-067211
Filing Date
2013-12-13
Accepted
2013-12-13 16:36:44
Documents
2
Group Members
BRIAN D. GROSSMANCHRISTOPHER M. JAMESPARTNER FUND MANAGEMENT GP, LLCPARTNER INVESTMENT MANAGEMENT GP, LLCPARTNER INVESTMENT MANAGEMENT, L.P.

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G v363024_sc13-g.htm SC 13G 150986
2 EXHIBIT 99.1 v363024_ex99-1.htm EX-99.1 8864
  Complete submission text file 0001144204-13-067211.txt   161630
Mailing Address 3344 N. TORREY PINES CT. SUITE 200 LA JOLLA CA 92037
Business Address 3344 N. TORREY PINES CT. SUITE 200 LA JOLLA CA 92037 (858) 875-8600
Orexigen Therapeutics, Inc. (Subject) CIK: 0001382911 (see all company filings)

IRS No.: 651178822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-83422 | Film No.: 131276562
SIC: 2834 Pharmaceutical Preparations

Mailing Address FOUR EMBARCADERO CENTER SUITE 3500 SAN FRANCISCO CA 94111
Business Address FOUR EMBARCADERO CENTER SUITE 3500 SAN FRANCISCO CA 94111 415-281-1022
Partner Fund Management, L.P. (Filed by) CIK: 0001442756 (see all company filings)

IRS No.: 262000428 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G